Novel Nanoparticle-Based Treatment and Imaging Modalities

Dear Colleagues,

Over the last twenty years, nanomaterials have been widely used in cancer research. Numerous reports suggest that nanoparticles have the potential to improve conventional therapeutic (e.g., chemotherapy) and imaging (e.g., MRI) modalities for cancer detection and treatment. Nanomaterials allow further development of novel experimental treatment and imaging strategies, including photothermal therapy, magnetic hyperthermia, and photoacoustic imaging. In addition, though to a lesser extent, nanoparticle-based imaging and treatment modalities have frequently been explored for other nonmalignant diseases, such as pulmonary fibrosis, AIDS, muscular dystrophy, etc. The results of this research suggest that some fundamental principles of cancer nanomedicine could potentially be used for the development of novel nanoparticle-based strategies for treatment and imaging of other disorders. In this Special Issue, we invite authors to report their recently developed nanoparticle-based modalities for diagnosis and/or treatment of various disease states. We also welcome reviewer articles with expert opinions and perspectives in the nanomedicine field.

Dr. Oleh Taratula
Dr. Olena Taratula
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.